Access Fee. In consideration of the licenses granted to CLDA pursuant to Section 3.1, CLDA shall pay to AVRX a one-time access fee of One Million U.S. Dollars (US$1,000,000) simultaneously with the execution hereof.
Appears in 2 contracts
Sources: License Agreement (Clinical Data Inc), License Agreement (Avalon Pharmaceuticals Inc)